L&K Biomed Successfully Concludes 'Factus' Live Surgery in Thailand, Accelerates Southeast Asian Market Expansion

Medical staff and related personnel participated in the 'Factus Live Surgery Workshop' are taking a group photo. Provided by L&K Bio

L&K Biomed, a company specializing in spinal implants, has begun targeting the Southeast Asian market by conducting a live surgery using its pectus excavatum treatment device, the "Factus (CastleLoc Pectus System)," in Thailand.

On May 20, L&K Biomed announced that it had successfully concluded the "Factus Live Surgery Workshop" at the Thai Society of Thoracic Surgeons (STST), which was held at Phramongkutklao Hospital in Bangkok, Thailand, from May 14 to 17.

This workshop was co-organized by Phramongkutklao Hospital, a leading education and general hospital under the Royal Thai Army, and the STST. The company explained that it focused on sharing the latest surgical techniques and clinical experience in pectus excavatum procedures with local medical professionals, while also highlighting the competitiveness of its Factus product.

The event featured Dr. Dawn Jaroszewski and Dr. Lisa McMahon—renowned U.S. experts in the field of pectus surgery—as invited speakers. They performed live surgeries on patients with pectus carinatum and pectus excavatum using L&K Biomed's CastleLoc Pectus System.

Following the surgeries, Dr. McMahon delivered a lecture on "Latest Techniques in Minimally Invasive Pectus Excavatum Surgery," sharing recent trends and clinical insights in the field of minimally invasive chest wall deformity surgery.

Dr. Jaroszewski is a thoracic surgeon at Mayo Clinic in the United States and currently serves as President of the Chest Wall International Group (CWIG). She is recognized as a global authority in adult chest wall deformity correction and minimally invasive Nuss procedures.

Dr. McMahon, affiliated with Phoenix Children's Hospital in the United States, is acknowledged for her high level of expertise in pediatric chest wall deformity surgeries. Notably, she visited L&K Biomed's headquarters last year to personally assess the technological capabilities and clinical applicability of the Factus system, and has since maintained ongoing academic exchanges.

The event drew approximately 200 medical professionals from the Thai Society of Thoracic Surgeons and experts in pectus surgery from the United States, attracting significant attention. It was regarded as an opportunity to share global trends and surgical expertise in pectus excavatum treatment based on real-world surgical cases.

In particular, the "CastleLoc Pectus System" used in the live surgeries received positive feedback from local medical professionals for its stable fixation and surgical convenience. The company emphasized that it was able to effectively demonstrate the clinical applicability and competitiveness of its product on site.

An L&K Biomed representative stated, "The pectus market in Thailand is at a growth stage, where the adoption of advanced global surgical techniques and expanded experience with the latest minimally invasive procedures is needed. We expect that this live surgery-based workshop, in collaboration with key opinion leaders (KOLs) in the U.S. pectus field, will enhance local medical professionals' understanding and help establish a foundation for market expansion."

The representative added, "Through this event, we strengthened academic exchanges with global medical professionals and achieved progress in expanding our clinical network and product recognition in the Southeast Asian market. Moving forward, we will continue to expand academic marketing and medical professional education focused on the Asian market, further enhancing the global competitiveness of the Factus product."

L&K Biomed is expected to accelerate its global market expansion for the Factus product by broadening its network among Southeast Asian medical professionals and strengthening its clinical foundation following this live surgery event in Thailand.

This content was produced with the assistance of AI translation services.